Similar Articles
Different Therapeutic Paths (Colchicine vs. Anakinra) in Two Patients With Schnitzler’s Syndrome
Marko BAREŠIĆ, Joško MITROVIĆ, Jadranka MOROVIĆ VERGLES, Branimir ANIĆ
DOI: 10.5606/ArchRheumatol.2016.6000
Occurrence of Ulcerative Colitis in a Patient With Adult-Onset Still's Disease: Coincidence or Correlated
Yun Jung CHOI, Wan-hee YOO
DOI: 10.5606/ArchRheumatol.2017.6182
Pneumatosis Intestinalis and Intestinal Perforation in a Patient Receiving Tocilizumab
Ben JACOBS, Ali JAWAD, Zozik FATTAH
DOI: 10.5606/ArchRheumatol.2018.6668
Effects of Tocilizumab Therapy on Serum Interleukin-33 and Interleukin-6 Levels in Patients With Rheumatoid Arthritis
In Ah CHOI, Sang Jin LEE, Won PARK, Sung Hwan PARK, Seung-cheol SHIM, Han Joo BAEK, Dae-Hyun YOO, Hyun Ah KIM, Soo Kon LEE, Yun Jong LEE, Young Eun PARK, Hoon-Suk CHA, Eun Young LEE, Eun Bong LEE, Yeong Wook SONG
DOI: 10.5606/ArchRheumatol.2018.6753
Body Mass Index and Clinical Response to Tocilizumab in Patients With Rheumatoid Arthritis
Hua HUANG, Han CEN, Li ZHOU, Ting-hui WANG, Wen QIN, Bin-hua XIE, Dong-Mei XIAO, Xiu-Di WU, Hua-Xiang WU
DOI: 10.5606/ArchRheumatol.2019.7146
Additional Benefit of Canakinumab on Proteinuria in a Case With Muckle-Wells Syndrome in Remission Under Anakinra
Ufuk İLGEN, Orhan KÜÇÜKŞAHİN
DOI: 10.5606/ArchRheumatol.2020.7378
Spontaneous Spinal Epidural Hematoma During Simultaneous Tocilizumab and Warfarin Use in a Patient With Rheumatoid Arthritis: Is There a Drug Interaction Between Tocilizumab and Oral Anticoagulants?
Seçilay GÜNEŞ, Haydar GÖK, Şebnem ATAMAN, Şehim KUTLAY
DOI: 10.46497/ArchRheumatol.2020.7579
Biologics in juvenile idiopathic arthritis-main advantages and major challenges: A narrative review
Amra ADROVIC, Mehmet YILDIZ, Oya KÖKER, Sezgin ŞAHİN, Kenan BARUT, Özgür KASAPÇOPUR
DOI: 10.46497/ArchRheumatol.2021.7953
Efficacy of anakinra treatment in pediatric rheumatic diseases: Our single-center experience
Ferhat Demir, Eda Gürler, Betül Sözeri
DOI: 10.46497/ArchRheumatol.2022.8998
Evaluation of the anti-RANKL monoclonal antibody in rheumatoid arthritis rats
Dawei Lv, Xiaodong Zhao
DOI: 10.46497/ArchRheumatol.2023.9240
The impact of COVID-19 on clinical course and treatment among patients with juvenile systemic sclerosis
Amra Adrovic, Mehmet Yıldız, Fatih Haşlak, Sezgin Şahin, Oya Köker, Aybüke Günalp, Kenan Barut, Özgür Kasapçopur
DOI: 10.46497/ArchRheumatol.2023.9636